Searched for
MOUNJARO
GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...- ₹85,000 Temple: Deepinder Goyal’s wearable is a health-tech gambleDeepinder Goyal’s ₹85,000 Temple wearable aims to track real-time body performance and brain blood circulation, but its technology lacks me...
- US FDA adds rare vision-loss warning to popular GLP-1 drugsThe US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including O...
- Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDAEli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (U...
- Ozempic wave boosts US cobblers and tailors as Americans tighten their beltsConsumers in the US are experiencing significant changes in their wardrobes due to weight-loss medications. Many individuals are opting for...
- WHO says medicines, surgery not first-line treatment for childhood obesityThe World Health Organization has released guidelines on treating obesity among children and adolescents. It emphasizes structured diets, p...
- The Nobel Prize week is kicking off in Stockholm with the medicine award for understanding immune system responseThis year's Nobel Prizes will commence on Monday with the medicine prize awarded at the Karolinska Institute. Last year, three scientists w...
- Nobel 2026: Ozempic, Mounjaro research tipped for medicine prizeThe 2026 Nobel season is set to reveal the winners of various prestigious awards, starting with medicine. The medicine prize is anticipated...
- India has biotech talent and know-how, but funding ecosystem lags: Lilly CEOEli Lilly intends to innovate in the weight-loss market, launching up to four new products in the coming years. The success of Mounjaro and...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Women tip the scale as weight-loss boom reaches tier-II citiesWhile startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- Top US doctor reveals truth about viral weight loss wonder drug Mounjaro. Is it safe or not after potential kidney problem claims?Beyond common side effects, regular use of Mounjaro may lead to serious health risks, including pancreatitis, kidney problems, and in rare ...
- Eli Lilly's obesity drug Mounjaro's India sales hit a sweet spot within six months of launchLilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales within ...
- Weight-loss drug Mounjaro crosses Rs 100 crore sales in 4 monthsThe drug clocked Rs 47-crore sales in July, double its June figure, according to data from prescriptions tracker PharmaTrac. If this month-...
- Weight-loss drug Mounjaro now in India: What is the price? What are the side effects? Here's all you need to knowEli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling with obesity an...
- Mounjaro: Here's all about the wonder antidiabetic medicine touted as the 'most powerful' weight-loss drugMounjaro is making headlines recently. This antidiabetic injectable drug has been touted as the most powerful weight-loss drug available. I...
Load More
